[1]孔慧,崔彦.CD40-ATP-P2X7/NLRP3炎症信号通路在糖尿病视网膜病变中的作用研究进展[J].眼科新进展,2021,41(9):879-882.[doi:10.13389/j.cnki.rao.2021.0184]
　KONG Hui,CUI Yan.Research progress of the CD40-ATP-P2X7/NLRP3 inflammatory pathway in diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(9):879-882.[doi:10.13389/j.cnki.rao.2021.0184]
点击复制

CD40-ATP-P2X7/NLRP3炎症信号通路在糖尿病视网膜病变中的作用研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年9期
页码:
879-882
栏目:
文献综述
出版日期:
2021-09-05

文章信息/Info

Title:
Research progress of the CD40-ATP-P2X7/NLRP3 inflammatory pathway in diabetic retinopathy
作者:
孔慧; 崔彦
250022　山东省济南市，山东中医药大学（孔慧）；250012　山东省济南市，山东大学齐鲁医院眼科（崔彦）
Author(s):
KONG Hui1; CUI Yan2
1.Shandong Traditional Chinese Medicine University,Jinan 250022,Shandong Province,China
2.Deparment of Ophthalmology,Qilu Hospital of Shandong University,Jinan 250012,Shandong Province,China
关键词:
糖尿病视网膜病变; 炎症; 三磷酸腺苷; 炎性小体NLRP3; 视网膜神经血管单元; 胶质细胞
Keywords:
diabetic retinopathy;  inflammation;  adenosine triphosphate;  NLRP3;  retinal neurovascular unit;  glial cells
分类号:
R774
DOI:
10.13389/j.cnki.rao.2021.0184
文献标志码:
A
摘要:
糖尿病视网膜病变是糖尿病的严重并发症。炎症反应在糖尿病视网膜病变的发生发展中起着重要的作用。在高糖状态下，糖尿病患者视网膜胶质细胞以及血管内皮细胞间通过CD40-ATP-P2X7受体信号通路相互作用，诱发视网膜神经血管单元炎症级联反应，造成中低度慢性炎症及视网膜损伤。本文回顾糖尿病视网膜病变炎症机制的研究进展，对近年来CD40-ATP-P2X7/NLRP3炎症信号通路参与糖尿病视网膜病变的临床及实验研究进行综述，探讨糖尿病视网膜病变中针对该通路可能的治疗策略。
Abstract:
Diabetic retinopathy (DR) is a serious complication of diabetes, in which inflammation response plays an important role. In the high-glucose state, retinal glial cells interact with vascular endothelial cells in diabetic patients through the CD40-ATP-P2X7 receptor signaling pathway, thus inducing the inflammatory cascade reaction of retinal neurovascular units, and resulting in moderate to low degree chronic inflammation and retinal damage. This study retrospectively reviewed the research progress on the inflammatory mechanism of DR, and summarized latest clinical and experimental studies on the involvement of the CD40-ATP-P2X7/NLRP3 signaling pathway in DR. We also discuss the possible therapeutic strategies targeting this pathway in DR.

参考文献/References:

［1］　KERN T S.Inflammation in diabetic retinopathy［J］.Prog Retin Eye Res,2011,30(5):343-358.
［2］　RBSAM A,PARIKH S,FORT P.Role of inflammation in diabetic retinopathy［J］.Int J Mol Sci,2018,19(4):942-973.
［3］　DUH E J,SUN J K,STITT A W.Diabetic retinopathy:current understanding,mechanisms,and treatment strategies［J］.JCI Insight,2017,2(14):93751.
［4］　SINCLAIR S H,SCHWARTZ S S.Diabetic retinopathy-an underdiagnosed and undertreated inflammatory,neuro-vascular complication of diabetes［J］.Front Endocrinol (Lausanne),2019,10:843.
［5］　ABCOUWER S F,GARDNER T W.Diabetic retinopathy:loss of neuroretinal adaptation to the diabetic metabolic environment［J］.Ann N Y Acad Sci,2014,1311:174-190.
［6］　TANG S,SCHEIFFARTH O F,THURAU S R,WILDNER G.Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy［J］.Ophthalmic Res,1993,25(3):177-185.
［7］　POWELL E D,FIELD R A.Diabetic retinopathy and rheumatoid arthritis［J］.Lancet,1964,2(7349):17-18.
［8］　BRUCKLACHER R M,PATEL K M,VANGUILDER H D,BIXLER G V,BARBER A J,ANTONETTI D A,et al.Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflflammatory response［J］.BMC Med Genomics,2008,13:1-26.
［9］　SERHAN C N.Resolution phase of inflammation：novel endogenous anti-inflammatory and proresolving lipid mediators and pathways ［J］．Annu Rev Immunol，2007,25:101-137．
［10］　 IDIT D B,ALON Z,RUTH A S,YAEL N,MOR D,DOV W,et al.Inflammation,angiogenesis and coagulation interplay in a variety of retinal diseases［J］.Acta Ophthalmol,2020,98:559-562.
［11］　AKHTAR-SCHFER I,WANG L,KROHNE T,XU H,LANGMANN T.Modulation of three key innate immune pathways for the most common retinal degenerative diseases［J］.EMBO Mol Med,2018,10(10):e8259.
［12］　ESPOSITO K,NAPPO F,MARFELLA R,GIUGLIANO G,GIUGLIANO F,CIOTOLA M,et al.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans:role of oxidative stress［J］.Circulation,2002,106(16):2067-2072.
［13］　CAI K,LUO Q,ZHU B,HAN L,WU D,DAI Z,et al.Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis［J］.BMC Nephrol,2016,17(1):191.
［14］　BOSS J D,SINGH P K,PANDYA H K,TOSI J,KIM C,TEWARI A,et al.Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy［J］.Invest Ophthalmol Vis Sci,2017,58(12):5594-5603.
［15］　CAI M,ZHANG X,LI Y,XU H.Toll-like receptor 3 activation drives the inflammatory response in oxygen-induced retinopathy in rats［J］.Br J Ophthalmol,2015,99(1):125-132.
［16］　NATHAN C,DING A.Nonresolving inflammation［J］.Cell,2010,140(6):871-882.
［17］　SUBAUSTE C S.The CD40-ATP-P2X (7) receptor pathway:cell to cell cross-talk to promote inflammation and programmed cell death of endothelial cells［J］.Front Immunol,2019,10:2958.
［18］　AL-KHARASHI A S.Role of oxidative stress,inflammation,hypoxia and angiogenesis in the development of diabetic retinopathy［J］.Saudi J Ophthalmol,2018,32(4):318-323.
［19］　SANTIAGO A R,BOIA R,AIRES I D,AMBRSIO A F,FERNANDES R.Sweet stress:coping with vascular dysfunction in diabetic retinopathy［J］.Front Physiol,2018,9:820.
［20］　SEMERARO F,MORESCALCHI F,CANCARINI A,RUSSO A,REZZOLA S,COSTAGLIOLA C.Diabetic retinopathy,a vascular and inflammatory disease:therapeutic implications［J］.Diabetes Metab,2019,45(6):517-527.
［21］　QUAN Y,JIANG C T,XUE B,ZHU S G,WANG X.High glucose stimulates TNF-a and MCP-1 expression in rat microglia via ROS and NF-kB pathways［J］.Acta Pharmacol Sin,2011,32:188-193.
［22］　DU L,ZHANG Y,CHEN Y,ZHU J,YANG Y A.Role of microglia in neurological disorders and their potentials as a therapeutic target［J］.Mol Neurobiol,2017,54(10):7567-7584.
［23］　MCMENAMIN P G,SABAN D R,DANDO S J.Immune cells in the retina and choroid:two different tissue environments that require different defenses and surveillance［J］.Prog Retin Eye Res,2019,70:85-98.
［24］　EMING S A,WYNN T A,MARTIN P.Inflammation and metabolism in tissue repair and regeneration［J］.Science,2017,356(6342):1026-1030.
［25］　COSTA G,PEREIRA T,NETO A M,CRISTVO A J,AMBRSIO A F,SANTOS P F.High glucose changes extracellular adenosine triphosphate levels in rat retinal cultures［J］.J Neurosci Res,2009,87(6):1375-1380.
［26］　GARDNER T W,DAVILA J R.The neurovascular unit and the pathophysiologic basis of diabetic retinopathy［J］.Graefes Arch Clin Exp Ophthalmol,2017,255(1):1-6.
［27］　NIAN S,LO A,MI Y,REN K,YANG D.Neurovascular unit in diabetic retinopathy:pathophysiological roles and potential therapeutical targets［J］.Eye Vis (Lond),2021,8(1):15.
［28］　PORTILLO J C,LOPEZ C Y,DUBYAK G R,KERN T S,MATSUYAMA S,SUBAUSTE C S.Ligation of CD40 in human müller cells induces P2X7 receptor-dependent death of retinal endothelial cells［J］.Invest Ophthalmol Vis Sci,2016,57(14):6278-6286.
［29］　NEUBAUER H,SETIADI P,GUENESDOGAN B,PINTO A ,MUEGGE A.Influence of glycaemic control on platelet bound CD40-CD40L system,P-selectin and soluble CD40 ligand in Type 2 diabetes［J］.Diabet Med,2010,27(4):384-390.
［30］　LAMINE L B,TURKI A,AL-KHATEEB G,SELLAMI N,AMOR H B,SARRAY S,et al.Elevation in circulating soluble CD40 ligand concentrations in type 2 diabetic retinopathy and association with its severity［J］.Exp Clin Endocrinol Diabetes,2020,128(5):319-324.
［31］　PORTILLO J A,GREENE J A,OKENKA G,MIAO Y,SHEIBANI N,KERN T S,et al.CD40 promotes the development of early diabetic retinopathy in mice［J］.Diabetologia,2014,57(10):2222-2231.
［32］　CAUWELS A,ROGGE E,VANDENDRIESSCHE B,SHIVA S,BROUCKAERT P.Extracellular ATP drives systemic inflammation,tissue damage and mortality［J］.Cell Death Dis,2014,5(3):e1102.
［33］　BUROW P,KLAPPERSTCK M,MARKWARDT F.Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages［J］.Pflugers Arch,2015,467(6):1215-1226.
［34］　DI VIRGILIO F,DAL BEN D,SARTI A C,FALZONI S.The P2X7 receptor in infection and inflammation［J］.Immunity,2017,47(1):15-31.
［35］　ROSSATO M,DI VINCENZO A,PAGANO C,EL H H,VETTOR R.The P2X7 receptor and NLRP3 axis in Non-Alcoholic fatty liver disease:a brief review［J］.Cells,2020,9(4):1047.
［36］　SOLINI A,NOVAK I.Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications［J］.Curr Opin Pharmacol,2019,47:75-81.
［37］　ZHOU R,DANG X,SPRAGUE R S,MUSTAFA S J,ZHOU Z.Alteration of purinergic signaling in diabetes:focus on vascular function［J］.J Mol Cell Cardiol,2020,140:1-9.
［38］　SHIBATA M,ISHIZAKI E,ZHANG T,FUKUMOTO M,BARAJAS-ESPINOSA A,LI T,et al.Purinergic vasotoxicity:role of the pore/oxidant/K(ATP) Channel/Ca(2+) pathway in P2X(7)-induced cell death in retinal capillaries［J］.Vision (Basel),2018,2(3):25.
［39］　PORTILLO J C,LOPEZ C Y,MIAO Y,TANG J,SHEIBANI N,KERN T S,et al.CD40 in retinal Müller cells induces p2x7-dependent cytokine expression in macrophages/microglia in diabetic mice and development of early experimental diabetic retinopathy ［J］.Diabetes,2017,66:483-493.
［40］　PLATANIA C,GIURDANELLA G,DI PAOLA L,LEGGIO G M,DRAGO F,SALOMONE S,et al.P2X7 receptor antagonism:implications in diabetic retinopathy［J］.Biochem Pharmacol,2017,138:130-139.
［41］　PLATANIA C B M,LAZZARA F,FIDILIO A,FRESTA C G,CONTI F,GIURDANELLA G,et al.Blood-retinal barrier protection against high glucose damage:the role of P2X7 receptor［J］.Biochem Pharmacol,2019,168,249-258.
［42］　PLATANIA C B M,GIURDANELLA G,DI PAOLA L,LEGGIO G M,DRAGO F,SALOMONE S,et al.P2X7 receptor antagonism:implications in diabetic retinopathy［J］.Biochem Pharmacol,2017,138,130-139.
［43］　CLAPP C,DIAZ-LEZAMA N,ADAN-CASTRO E,RAMIREZ-HERNANDEZ G,MORENO-CARRANZA B,SARTI A C,et al.Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes［J］.Acta Diabetol,2019,56(9):1031-1036.
［44］　PAVLOU S,AUGUSTINE J,CUNNING R,HARKIN K,STITT A W,XU H,et al.Attenuating diabetic vascular and neuronal defects by targeting P2rx7［J］.Int J Mol Sci,2019,20(9):2101.
［45］　DI VIRGILIO F,DAL BEN D,SARTI A C,FALZONI S.The P2X7 receptor in infection and inflammation［J］.Immunity,2017,47(1):15-31.
［46］　WANG H,ZHANG Y,MA X,WANG W,XU X,HUANG M,et al.Spinal TLR4/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception［J］.J Inflamm Res,2020,13:571-582.
［47］　FAN X,MA W,ZHANG Y,ZHANG L.P2X7 receptor (P2X7R) of microglia mediates neuroinflammation by regulating (NOD)-like receptor protein 3 (NLRP3) Inflammasome-Dependent inflammation after spinal cord injury［J］.Med Sci Monit,2020,26:e925491.
［48］　ZHANG Y,XU Y,SUN Q,XUE S,GUAN H,JI M.Activation of P2XR-NLRP3 pathway in retinal microglia contribute to retinal ganglion cells death in chronic ocular hypertension (COH)［J］.Exp Eye Res,2019,188:107771.
［49］　FRANCESCHINI A,CAPECE M,CHIOZZI P,FALZONI S,SANZ J M,SARTI A C,et al.The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein［J］.FASEB J,2015,29(6):2450-2461.
［50］　ZHANG Y,LV X,HU Z,YE X,ZHENG X,DING Y,et al.Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction［J］.Cell Death Dis,2017,8(7):e2941.
［51］　石蕊,王博,杨乐.非诺贝特对糖尿病视网膜病变小鼠视网膜神经细胞的保护作用及机制［J］.眼科新进展,2019,39(6):528-531.
SHI R,WANG B,YANG L.Protective effect and mechanism of Fenofibrate on retinal neuro cells in mice with diabetic retinopathy［J］.Rec Adv Ophthalmol,2019,39(6):528-531.
［52］　SINGER M A,KERMANY D S,WATERS J,JANSEN M E,TYLER L.Diabetic macular edema:it is more than just VEGF［J］.F1000 Res,2016,5:F1000 Faculty Rev-1019.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]兰文 陆燕 王春红 胡钦瑞 黄振平.糖尿病视网膜病变炎症的研究新进展[J].眼科新进展,2013,33(2):000.
[12]刘安琪,左中夫,吴传玲,等.Netrin-1对糖尿病视网膜病变大鼠的保护作用[J].眼科新进展,2020,40(1):011.[doi:10.13389/j.cnki.rao.2020.0003]
　LIU Anqi,ZUO Zhongfu,WU Chuanling,et al.Protective effect of Netrin-1 on rats with diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(9):011.[doi:10.13389/j.cnki.rao.2020.0003]
[13]张凤俊,李晶明,刘秋平.糖尿病视网膜病变发病机制及潜在治疗研究进展[J].眼科新进展,2020,40(7):677.[doi:10.13389/j.cnki.rao.2020.0156]
　ZHANG Fengjun,LI Jingming,LIU Qiuping.Pathogenesis and potential treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(9):677.[doi:10.13389/j.cnki.rao.2020.0156]
[14]唐磊,徐国彤,张敬法.褪黑素治疗糖尿病视网膜病变的研究进展[J].眼科新进展,2021,41(7):684.[doi:10.13389/j.cnki.rao.2021.0142]
　TANG Lei,XU Guotong,ZHANG Jingfa.Progress of melatonin in the treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(9):684.[doi:10.13389/j.cnki.rao.2021.0142]
[15]司长峰,卜荔,徐楠,等.柴胡皂苷D对糖尿病视网膜病变大鼠的治疗作用[J].眼科新进展,2021,41(10):925.[doi:10.13389/j.cnki.rao.2021.0194]
　SI Changfeng,BU Li,XU Nan,et al.Therapeutical effect of Saikosaponin D on diabetic retinopathy of rats[J].Recent Advances in Ophthalmology,2021,41(9):925.[doi:10.13389/j.cnki.rao.2021.0194]
[16]孔慧,崔彦.糖尿病视网膜病变中视网膜内皮细胞功能障碍的研究进展[J].眼科新进展,2022,42(9):753.[doi:10.13389/j.cnki.rao.2022.0155]
　KONG Hui,CUI Yan.Research progress on retinal endothelial cell dysfunction in diabetic retinopathy[J].Recent Advances in Ophthalmology,2022,42(9):753.[doi:10.13389/j.cnki.rao.2022.0155]
[17]陈洪良,施健,娄雪莹,等.中性粒细胞胞外陷阱在糖尿病视网膜病变中作用的研究进展[J].眼科新进展,2023,43(9):747.[doi:10.13389/j.cnki.rao.2023.0150]
　CHEN Hongliang,SHI Jian,LOU Xueying,et al.Research progress on the effect of neutrophil extracellular traps in diabetic retinopathy[J].Recent Advances in Ophthalmology,2023,43(9):747.[doi:10.13389/j.cnki.rao.2023.0150]
[18]张敬法.炎症在糖尿病视网膜病变中的作用：发病机制及治疗策略[J].眼科新进展,2024,44(1):001.[doi:10.13389/j.cnki.rao.2024.0001]
　ZHANG Jingfa.Role of inflammation in diabetic retinopathy: pathogenesis and treatment strategies[J].Recent Advances in Ophthalmology,2024,44(9):001.[doi:10.13389/j.cnki.rao.2024.0001]
[19]刘磊,刘珊珊,胡菲菲,等.吴茱萸碱调节cAMP/PKA信号通路在糖尿病大鼠视网膜损伤中的作用[J].眼科新进展,2024,44(2):094.[doi:10.13389/j.cnki.rao.2024.0019]
　LIU Lei,LIU Shanshan,HU Feifei,et al.Impact of evodiamine on retinal injury in diabetic rats by regulating cyclic adenosine monophosphate/protein kinase A signaling pathway[J].Recent Advances in Ophthalmology,2024,44(9):094.[doi:10.13389/j.cnki.rao.2024.0019]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81100658）；山东省自然科学基金资助（编号：ZR2020MH174）
更新日期/Last Update: 2021-09-05